Ellaine M. Salvador

Josef Schneider Str. 11
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Advancing glioblastoma research by establishing a whole brain slice model.

Advancing glioblastoma research by establishing a whole brain slice model.

Journal: Frontiers in oncology
Published: February 20, 2026

Heart Rate Variability, Microvascular Dysfunction, and Inflammation: Exploring the Potential of taVNS in Managing Heart Failure in Type 2 Diabetes Mellitus.

Heart Rate Variability, Microvascular Dysfunction, and Inflammation: Exploring the Potential of taVNS in Managing Heart Failure in Type 2 Diabetes Mellitus.

Journal: Biomolecules
Published: February 10, 2025

Resting After Learning Facilitates Memory Consolidation and Reverses Spatial Reorientation Impairments in 'New Surroundings' in 3xTg-AD Mice.

Resting After Learning Facilitates Memory Consolidation and Reverses Spatial Reorientation Impairments in 'New Surroundings' in 3xTg-AD Mice.

Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024

Implications of cell's electrical properties for standard of care in glioblastoma therapy: Comment on "The distinguishing electrical properties of cancer cells" by E. Di Gregorio et al.

Implications of cell's electrical properties for standard of care in glioblastoma therapy: Comment on "The distinguishing electrical properties of cancer cells" by E. Di Gregorio et al.

Journal: Physics of life reviews
Published: July 24, 2023

Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier.

Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier.

Journal: Pharmaceutics
Published: December 20, 2022

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields).

Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields).

Journal: Cancers
Published: September 30, 2022

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo.

Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood-Brain Barrier In Vitro and In Vivo.

Journal: Biomolecules
Published: August 29, 2022

Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood-Brain Barrier (BBB).

Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood-Brain Barrier (BBB).

Journal: Pharmaceutics
Published: July 26, 2022

MicroRNA-21-5p functions via RECK/MMP9 as a proalgesic regulator of the blood nerve barrier in nerve injury.

MicroRNA-21-5p functions via RECK/MMP9 as a proalgesic regulator of the blood nerve barrier in nerve injury.

Journal: Annals of the New York Academy of Sciences
Published: June 18, 2022

The Mechanisms of Action of Tumor Treating Fields.

The Mechanisms of Action of Tumor Treating Fields.

Journal: Cancer research
Published: March 17, 2022

Microvascular Barrier Protection by microRNA-183 via FoxO1 Repression: A Pathway Disturbed in Neuropathy and Complex Regional Pain Syndrome.

Microvascular Barrier Protection by microRNA-183 via FoxO1 Repression: A Pathway Disturbed in Neuropathy and Complex Regional Pain Syndrome.

Journal: The journal of pain
Published: November 09, 2021

Senescence and associated blood-brain barrier alterations in vitro.

Senescence and associated blood-brain barrier alterations in vitro.

Journal: Histochemistry and cell biology
Published: April 23, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026